Eric P van der Veer
Overview
Explore the profile of Eric P van der Veer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
565
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dauksaite V, Tas A, Wachowius F, Spruit A, van Hemert M, Snijder E, et al.
Nucleic Acid Ther
. 2023 Oct;
33(6):381-385.
PMID: 37782140
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused the current worldwide pandemic and the associated coronavirus disease 2019 with potentially lethal outcome. Although effective vaccines strongly contributed to reduce...
2.
de Bruin R, Vogel G, Prins J, Duijs J, Bijkerk R, van der Zande H, et al.
Epigenomes
. 2021 Dec;
4(1).
PMID: 34968236
In the pathophysiologic setting of acute and chronic kidney injury, the excessive activation and recruitment of blood-borne monocytes prompts their differentiation into inflammatory macrophages, a process that leads to progressive...
3.
Zhang H, Prins J, Vreeken D, Florijn B, de Bruin R, van Hengel O, et al.
Innate Immun
. 2020 Nov;
27(2):118-132.
PMID: 33241976
In response to inflammatory cytokines and chemokines, monocytes differentiate into macrophages. Comprehensive analysis of gene expression regulation of neuronal guidance cue (NGC) ligands and receptors in the monocyte-to-macrophage differentiation process...
4.
Zhang H, Bredewold E, Vreeken D, Duijs J, de Boer H, Kraaijeveld A, et al.
Int J Mol Sci
. 2020 Sep;
21(17).
PMID: 32887275
Atherosclerosis is the underlying pathology in a major part of cardiovascular disease, the leading cause of mortality in developed countries. The infiltration of monocytes into the vessel walls of large...
5.
Bezhaeva T, Geelhoed W, Wang D, Yuan H, van der Veer E, van Alem C, et al.
Biomaterials
. 2018 Dec;
194:47-56.
PMID: 30580195
Tissue engineered blood vessels (TEBVs) hold great promise for clinical use in patients with end stage renal disease (ESRD) requiring vascular access for hemodialysis. A promising way to make TEBVs...
6.
Bezhaeva T, de Vries M, Geelhoed W, van der Veer E, Versteeg S, van Alem C, et al.
FASEB J
. 2018 Jun;
:fj201800437R.
PMID: 29882709
The pathophysiology of arteriovenous fistula (AVF) maturation failure is not completely understood but impaired outward remodeling (OR) and intimal hyperplasia are thought to be contributors. This adverse vascular response after...
7.
Bijkerk R, Trimpert C, van Solingen C, de Bruin R, Florijn B, Kooijman S, et al.
Am J Physiol Renal Physiol
. 2018 May;
315(4):F1129-F1138.
PMID: 29846108
Fine-tuning of the body's water balance is regulated by vasopressin (AVP), which induces the expression and apical membrane insertion of aquaporin-2 water channels and subsequent water reabsorption in the kidney....
8.
Kortekaas K, de Vries D, Roest M, Reinders M, van der Veer E, Klautz R, et al.
Am J Transl Res
. 2018 Apr;
10(3):816-826.
PMID: 29636871
The pathophysiology of ischemia/reperfusion (I/R) injury is complex and poorly understood. Animal studies imply platelet activation as an initiator of the inflammatory response upon reperfusion. However, it remains unclear whether...
9.
Florijn B, Bijkerk R, van der Veer E, van Zonneveld A
Cardiovasc Res
. 2017 Nov;
114(2):210-225.
PMID: 29186452
Cardiovascular disease (CVD) is the primary cause of death among men and women worldwide. Nevertheless, our comprehension of how CVD progresses in women and elicits clinical outcomes is lacking, leading...
10.
van Alem C, Boonstra M, Prins J, Bezhaeva T, van Essen M, Ruben J, et al.
Nephrol Dial Transplant
. 2017 Oct;
33(1):44-53.
PMID: 28992069
Background: Treatment of inflammatory kidney diseases with systemic high-dose glucocorticoids (GCs) has severe side effects. Liposomal encapsulation could facilitate local delivery of GCs to the inflamed kidney, as liposomes encapsulate...